scholarly journals Rehabilitating Form, Function and Natural Aesthetics with Onlay Ceramic IPS Empress Esthetic®: Evidence and Versatility

2018 ◽  
Vol 20 (2) ◽  
pp. 17-29
Author(s):  
Juan Carlos Ramírez Barrantes DDS, MSD, PhD

Clinical research and in vitro laboratory tests have enabled the development and improvement of dental ceramics. Comprehension of the physical and mechanical properties of this material is essential, in order to ensure a functional, aesthetic and long-lasting posterior ceramic restoration. The clinical protocol for onlay preparation involves important considerations in treatment planning, such as selection of the restorative material, biomechanical design, color selection, dental substrates conditioning and adhesive cementation. This article discusses a brief review on the topic and  a case presentation in which a posterior tooth was rehabilitated with an IPS Empress Esthetic® ceramic onlay.

2018 ◽  
Vol 20 (2) ◽  
pp. 17-29
Author(s):  
Juan Carlos Ramírez Barrantes DDS, MSD, PhD

Clinical research and in vitro laboratory tests have enabled the development and improvement of dental ceramics. Comprehension of the physical and mechanical properties of this material is essential, in order to ensure a functional, aesthetic and long-lasting posterior ceramic restoration. The clinical protocol for onlay preparation involves important considerations in treatment planning, such as selection of the restorative material, biomechanical design, color selection, dental substrates conditioning and adhesive cementation. This article discusses a brief review on the topic and  a case presentation in which a posterior tooth was rehabilitated with an IPS Empress Esthetic® ceramic onlay.


Planta Medica ◽  
2015 ◽  
Vol 81 (16) ◽  
Author(s):  
R Bertóti ◽  
Á Alberti ◽  
A Böszörményi ◽  
R Könye ◽  
T Horváth ◽  
...  

2020 ◽  
Vol 65 (9-10) ◽  
pp. 3-7
Author(s):  
V. V. Gostev ◽  
Yu. V. Sopova ◽  
O. S. Kalinogorskaya ◽  
M. E. Velizhanina ◽  
I. V. Lazareva ◽  
...  

Glycopeptides are the basis of the treatment of infections caused by MRSA (Methicillin-Resistant Staphylococcus aureus). Previously, it was demonstrated that antibiotic tolerant phenotypes are formed during selection of resistance under the influence of high concentrations of antibiotics. The present study uses a similar in vitro selection model with vancomycin. Clinical isolates of MRSA belonging to genetic lines ST8 and ST239, as well as the MSSA (ATCC29213) strain, were included in the experiment. Test isolates were incubated for five hours in a medium with a high concentration of vancomycin (50 μg/ml). Test cultures were grown on the medium without antibiotic for 18 hours after each exposure. A total of ten exposure cycles were performed. Vancomycin was characterized by bacteriostatic action; the proportion of surviving cells after exposure was 70–100%. After selection, there was a slight increase in the MIC to vancomycin (MIC 2 μg/ml), teicoplanin (MIC 1.5–3 μg/ml) and daptomycin (MIC 0.25–2 μg/ml). According to the results of PAP analysis, all strains showed an increase in the area under curve depending on the concentration of vancomycin after selection, while a heteroresistant phenotype (with PAP/AUC 0.9) was detected in three isolates. All isolates showed walK mutations (T188S, D235N, E261V, V380I, and G223D). Exposure to short-term shock concentrations of vancomycin promotes the formation of heteroresistance in both MRSA and MSSA. Formation of VISA phenotypes is possible during therapy with vancomycin.


2002 ◽  
Vol 5 (6) ◽  
pp. 473-480
Author(s):  
Bentham Science Publisher A.N. Alexandrov ◽  
Bentham Science Publisher V.Yu. Alakhov ◽  
Bentham Science Publisher A.I. Miroshnikov

Author(s):  
Mahmoud A. Al-Sha'er ◽  
Mutasem O. Taha

Introduction: Tyrosine threonine kinase (TTK1) is a key regulator of chromosome segregation. TTK targeting received recent concern for the enhancement of possible anticancer therapies. Objective: In this regard we employed our well-known method of QSAR-guided selection of best crystallographic pharmacophore(s) to discover considerable binding interactions that anchore inhibitors into TTK1 binding site. Method:Sixtyone TTK1 crystallographic complexes were used to extract 315 pharmacophore hypotheses. QSAR modeling was subsequently used to choose a single crystallographic pharmacophore that when combined with other physicochemical descriptors elucidates bioactivity discrepancy within a list of 55 miscellaneous inhibitors. Results: The best QSAR model was robust and predictive (r2(55) = 0.75, r2LOO = 0.72 , r2press against external testing list of 12 compounds = 0.67), Standard error of estimate (training set) (S)= 0.63 , Standard error of estimate (testing set)(Stest) = 0.62. The resulting pharmacophore and QSAR models were used to scan the National Cancer Institute (NCI) database for new TTK1 inhibitors. Conclusion: Five hits confirmed significant TTK1 inhibitory profiles with IC50 values ranging between 11.7 and 76.6 micM.


2000 ◽  
Vol 15 (4) ◽  
pp. 297-308 ◽  
Author(s):  
NAOZUMI TERAMOTO ◽  
YUKIO IMANISHI ◽  
YOSHIHIRO ITO

Sign in / Sign up

Export Citation Format

Share Document